全文获取类型
收费全文 | 1081篇 |
免费 | 111篇 |
国内免费 | 62篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 28篇 |
妇产科学 | 16篇 |
基础医学 | 159篇 |
口腔科学 | 42篇 |
临床医学 | 138篇 |
内科学 | 383篇 |
皮肤病学 | 10篇 |
神经病学 | 112篇 |
特种医学 | 8篇 |
外科学 | 96篇 |
综合类 | 14篇 |
预防医学 | 52篇 |
眼科学 | 18篇 |
药学 | 75篇 |
肿瘤学 | 102篇 |
出版年
2023年 | 4篇 |
2022年 | 17篇 |
2021年 | 19篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 30篇 |
2017年 | 8篇 |
2016年 | 15篇 |
2015年 | 19篇 |
2014年 | 40篇 |
2013年 | 39篇 |
2012年 | 59篇 |
2011年 | 60篇 |
2010年 | 26篇 |
2009年 | 29篇 |
2008年 | 55篇 |
2007年 | 106篇 |
2006年 | 48篇 |
2005年 | 54篇 |
2004年 | 51篇 |
2003年 | 42篇 |
2002年 | 45篇 |
2001年 | 42篇 |
2000年 | 43篇 |
1999年 | 40篇 |
1998年 | 26篇 |
1997年 | 13篇 |
1996年 | 17篇 |
1995年 | 12篇 |
1994年 | 9篇 |
1993年 | 9篇 |
1992年 | 28篇 |
1991年 | 19篇 |
1990年 | 15篇 |
1989年 | 38篇 |
1988年 | 15篇 |
1987年 | 22篇 |
1986年 | 21篇 |
1985年 | 19篇 |
1984年 | 15篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1976年 | 4篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1969年 | 4篇 |
排序方式: 共有1254条查询结果,搜索用时 1 毫秒
21.
22.
23.
V. Cordesse T. Jametal C. Guy S. Lefebvre M. Roussel J. Ruggeri P. Schimmel J. Holstein V. Meininger 《Revue neurologique》2013,169(6-7):476-484
Neurological diseases are characterized by the complexity of care and by a constant and changing disability. More and more frequently, their impact on the clinical pathway remains unknown. Seven postgraduate rehabilitation students (Master coordination du handicap, université Pierre-et-Marie-Curie, Paris) reconstructed the clinical pathway of 123 patients with various neurological diseases: multiple sclerosis, Alzheimer disease, amyotrophic lateral sclerosis, spinal trauma, Parkinson disease and brain tumors. There was a significant correlation between disease duration and the number of specialists involved in care, the number of prescribed drugs and the number of short-term hospitalizations; there was no correlation with age. This result suggests that with time an increasing number of complications related to the initial neurological disease developed. Hospitalization in rehabilitation units was highly correlated with the degree of disability and also with the help received by the patients during the course of their disease. This result suggests that these hospitalizations were a direct consequence of burn out among relatives. General practitioners (GP) were highly involved only during the initial part of the pathway, and their involvement rapidly declined thereafter, suggesting a probable relation with the specificities and the complexity of care for neurological diseases which induces a progressive transfer of responsibilities from the GP to the hospital. Social care was always incomplete and occurred too late during the course of the disease. The feeling by the patients that their care pathway was chaotic was highly correlated with the quality of the information given to the patient at the time of the announcement of their disease. This study confirms that cares for neurological diseases is highly specific and that expert centers and coordination networks are in a key position to ensure an efficient care pathway. 相似文献
24.
Miknyoczki S Chang H Grobelny J Pritchard S Worrell C McGann N Ator M Husten J Deibold J Hudkins R Zulli A Parchment R Ruggeri B 《Molecular cancer therapeutics》2007,6(8):2290-2302
The effect of the potent and selective poly(ADP-ribose) (PAR) polymerase-1 [and PAR polymerase-2] inhibitor CEP-8983 on the ability to sensitize chemoresistant glioblastoma (RG2), rhabdomyosarcoma (RH18), neuroblastoma (NB1691), and colon carcinoma (HT29) tumor cells to temozolomide- and camptothecin-induced cytotoxicity, DNA damage, and G(2)-M arrest and on the potentiation of chemotherapy-induced myelotoxicity was evaluated using in vitro assays. In addition, the effect of the prodrug CEP-9722 in combination with temozolomide and/or irinotecan on PAR accumulation and tumor growth was also determined using glioblastoma and/or colon carcinoma xenografts relative to chemotherapy alone. CEP-8983 sensitized carcinoma cells to the growth-inhibitory effects of temozolomide and/or SN38 increased the fraction of and/or lengthened duration of time tumor cells accumulated in chemotherapy-induced G(2)-M arrest and sensitized tumor cells to chemotherapy-induced DNA damage and apoptosis. A granulocyte-macrophage colony-forming unit colony formation assay showed that coincubation of CEP-8983 with temozolomide or topotecan did not potentiate chemotherapy-associated myelotoxicity. CEP-9722 (136 mg/kg) administered with temozolomide (68 mg/kg for 5 days) or irinotecan (10 mg/kg for 5 days) inhibited significantly the growth of RG2 tumors (60%) or HT29 tumors (80%) compared with temozolomide or irinotecan monotherapy, respectively. In addition, CEP-9722 showed "stand alone" antitumor efficacy in these preclinical xenografts. In vivo biochemical efficacy studies showed that CEP-9722 attenuated PAR accumulation in glioma xenografts in a dose- and time-related manner. These data indicate that CEP-8983 and its prodrug are effective chemosensitizing agents when administered in combination with select chemotherapeutic agents against chemoresistant tumors. 相似文献
25.
Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets 总被引:3,自引:0,他引:3
K Nishio Y Fujimura K Niinomi Y Takahashi A Yoshioka H Fukui Y Usami K Titani Z M Ruggeri T S Zimmerman 《American journal of hematology》1990,33(4):261-266
Botrocetin, a protein isolated from the venom of the snake Bothrops jararaca, induces platelet aggregation/agglutination by von Willebrand factor (vWF) binding to the membrane glycoprotein (GP) Ib, an action resembling that of ristocetin. However, some differences in the interaction between vWF and platelet GPIb induced by these two substances have been reported. We have recently shown that the GPIb binding domain on the vWF molecule, in both instances, resides in the tryptic 52/48 kDa fragment extending from amino acid residue 449 to 728 of the constituent subunit. In the present report, we demonstrate that botrocetin does not induce agglutination of formalin-fixed platelets from a patient with Bernard-Soulier syndrome congenitally lacking GPIb and GPIX as well as GPV, a finding similar to that shown with ristocetin. A monoclonal antibody against GPIb (AP-1) inhibits either ristocetin- or botrocetin-dependent vWF binding to formalin-fixed platelets from normal individuals. Therefore, botrocetin-induced vWF binding to formalin-fixed platelets may reflect the interaction between vWF and platelet GPIb. To strengthen this concept, we have now found that heightened botrocetin-induced type IIB vWF binding to platelet GPIb causes hyperagglutination of normal platelets. 相似文献
26.
Sarah Tosato Martina Zanoni Chiara Bonetto Federica Tozzi Clyde Francks Elisa Ira Simona Tomassi Mariaelena Bertani Dan Rujescu Ina Giegling David St Clair Michele Tansella Mirella Ruggeri Pierandrea Muglia 《Neuromolecular medicine》2014,16(4):742-751
Neuregulin 1 (NRG1) and v-erb-a erythroblastic leukemia viral oncogene homolog 4 (ErbB4) have been extensively studied in schizophrenia susceptibility because of their pivotal role in key neurodevelopmental processes. One of the reasons for the inconsistencies in results could be the fact that the phenotype investigated has mostly the diagnosis of schizophrenia per se, which is widely heterogeneous, both clinically and biologically. In the present study we tested, in a large cohort of 461 schizophrenia patients recruited in Scotland, whether several SNPs in NRG1 and/or ErbB4 are associated with schizophrenia symptom dimensions as evaluated by the Positive and Negative Syndrome Scale (PANSS). We then followed up nominally significant results in a second cohort of 439 schizophrenia subjects recruited in Germany. Using linear regression, we observed two different groups of polymorphisms in NRG1 gene: one showing a nominal association with higher scores of the PANSS positive dimension and the other one with higher scores of the PANSS negative dimension. Regarding ErbB4, a small cluster located in the 5′ end of the gene was detected, showing nominal association mainly with negative, general and total dimensions of the PANSS. These findings suggest that some regions of NRG1 and ErbB4 are functionally involved in biological processes that underlie some of the phenotypic manifestations of schizophrenia. Because of the lack of significant association after correction for multiple testing, our analyses should be considered as exploratory and hypothesis generating for future studies. 相似文献
27.
M. Ruggeri 《Neurological sciences》2014,35(1):45-47
Migraine is a primary headache which World Health Organization ranks in 19th place in the list of disabling diseases. In Europe, in 2004, the total costs for migraine were quantified by Stovner and Berg, Eur J Neurol, 12(s1) (2005) at €27 billion. The objective of this study is to provide an estimate of the incremental cost-effectiveness ratio (ICER) of the treatment of chronic migraine with Botox compared to treatment with placebo in the perspective of the Italian National Health Service and society. To do this we studied the disease progression in a cohort of 688 individuals (patients enrolled in the study PREEMPT) via the application of a Markov model. Over a period of 2 years, the total costs of the experimental arm of the model amounted to €3,274 compared with a gain of 1.34 QALYs. In contrast, the costs of the control arm amounted to €2,395 with a gain of 1.24 QALYs. It follows that the incremental costs amounted to €889 compared to an incremental gain of 0.09 QALYs in favor of the experimental arm. The relationship between costs and incremental QALYs generated an ICER of €9,407/QALY. The incremental cost-effectiveness ratio, therefore, is favorable compared to the value usually considered by NICE as a threshold limit for reimbursement which ranges between €20,000 and €40,000/QALY. 相似文献
28.
Interindividual variations in the ability to perform visuospatial mental transformations have been investigated extensively, in particular through mental rotation tasks. However, the impact of early visual processes on performance has been largely ignored. To clarify this issue, we explored the time-course of early visual processing (from 0 to 450 ms poststimulus) using event-related potentials topographic analyses. The main findings demonstrated a significant link between early attentional processes and accuracy scores occurring more than five seconds later, as well as a strong association between spatial covariance and microstate topographies exhibiting substantial gender differences. More specifically, the results indicated that, in a classical mental rotation task, the male brain expends more time processing visual-spatial information resulting in a longer bilateral positive potential at posterior-occipital sites. In comparison, the female brain initiates earlier processing of non-spatial information resulting in a faster transition from a bilateral positive potential of posterior-occipital sites to a negative potential at central-frontal sites. These findings illustrate how a more complete utilization of the spatiotemporal information contained in EEG recordings can provide important insights about the impact of early visual processes on interindividual differences, particularly across gender, and thus shed new light on alternate cognitive strategies. 相似文献
29.
Martina Lenzuni Giulia Suarato Dalila Miele Riccardo Carzino Marco Ruggeri Rosalia Bertorelli Giuseppina Sandri Athanassia Athanassiou 《RSC advances》2021,11(39):24345
Drug-eluting stents (DES) have been widely used for the treatment of cardiovascular diseases. Nevertheless, chronic inflammation and delayed re-endothelialization still represent challenges for their clinical use. In the present work, we developed novel bilayer coatings for stent applications that could overcome these limitations, exclusively using biodegradable plant-based drugs and polymers. In particular, stainless steel surfaces were coated with rutin-loaded zein (the active layer) and cross-linked alginate (the sacrificial layer) via facile dip and spray coating methods. Various mechanical tests and analysis tools, such as infrared spectroscopy, water contact angle measurements, and scanning electron microscopy were used to characterize the coated surfaces. Degradation and release studies of the films were extensively carried out and compared. The release rate of rutin from the bilayer coating reached 66.1 ± 3.2% within 24 hours of incubation (initial burst period), while the rest of the drug was released over 21 days in a sustained manner. Antioxidant assays confirmed that rutin retained its free radical scavenging ability after being eluted in phosphate buffer at 37 °C. In vitro results with human fibroblasts and endothelial cells suggested that the coating materials and their degradation products are highly biocompatible. In conclusion, our novel drug-eluting coatings, fabricated with natural biodegradable polymers, are promising materials for DES applications, allowing a sustained drug delivery and improving the biocompatibility of cardiovascular implanted devices.Zein-based biodegradable bilayer coatings were successfully prepared and characterized. Release profiles, antioxidant potential, and biocompatibility were investigated, aiming for more sustainable coatings for drug-eluting stents. 相似文献
30.
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD
Antonino Di Stefano Claudia Sangiorgi Isabella Gnemmi Paolo Casolari Paola Brun Fabio L.M. Ricciardolo Marco Contoli Alberto Papi Pio Maniscalco Paolo Ruggeri Giuseppe Girbino Francesco Cappello Stelios Pavlides Yike Guo Kian Fan Chung Peter J. Barnes Ian M. Adcock Bruno Balbi Gaetano Caramori 《Chest》2018,153(4):851-862